CH505 TF mRNA-gp160

· National Institute of Allergy and Infectious Diseases (NIAID)

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CH505 TF mRNA-gp160, covering 2026-01-14 to 2026-01-14. Get the full timeline:

Most recent: Clinical Trial Update: A Clinical Trial to Evaluate the Safety and Immunogenicity of CH505M5 N197D mRNA-gp160 Followed by CH505 TF mRNA-gp160 in Adults in Overall Good Health Without HIV [Phase 1]

See pricing